19 Feb Discovery Radio – Episode #82: The CONTAIN COVID Convalescent Plasma Clinical Trial
A critically important national, multi-institutional clinical trial is underway, and the CTSI is part of it, all in the hopes of finding an effective treatment today and perhaps in the future. Learn about the CONTAIN COVID Convalescent Plasma clinical trial, inside this edition of CTSI Discovery Radio!
Guests
Christopher P. Austin, MD
Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Rahul Nanchal, MD
Professor, Department of Medicine (Pulmonary), MCW; Co-Principal Investigator, CONTAIN COVID, F&MCW
Executive Vice President for Research, VBRI; Professor, Department of Medicine (Biochemistry, and Pharmacology & Toxicology), MCW
More Information
- Clinical Trials Office, MCW
https://ctsi.mcw.edu/cto/ - National Center for Advancing Translational Sciences (NCATS)
https://ncats.nih.gov/ - Clinical & Translation Science Awards (CTSA) National Consortium
https://ctsi.mcw.edu/about/ctsa/ - Versiti Blood Center of Wisconsin Convalescent Plasma Donation Program
https://www.versiti.org/home/convalescent-plasma-donations - COVID-19 Coronavirus Information, MCW
https://covid19.mcw.edu/ - COVID-19 Data & Definitions, MCW
https://covid19.mcw.edu/data-and-definitions